Esperion Therapeutics
ESPR
#6676
Rank
NZ$1.46 B
Marketcap
NZ$5.69
Share price
0.00%
Change (1 day)
32.06%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Last known market cap: NZ$1.46 Billion

As of November 2026 Esperion Therapeutics has a market cap of NZ$1.46 Billion. This makes Esperion Therapeutics the world's 6676th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.46 B-11.4%
2025NZ$1.65 B107.61%
2024NZ$0.79 B48.15%
2023NZ$0.53 B-25.64%
2022NZ$0.72 B62.19%
2021NZ$0.44 B-52.26%
2020NZ$0.93 B-61.64%
2019NZ$2.43 B32.35%
2018NZ$1.83 B-24.26%
2017NZ$2.42 B495.78%
2016NZ$0.40 B-44.34%
2015NZ$0.73 B-30.25%
2014NZ$1.04 B309.35%
2013NZ$0.25 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$299.21 B 20,321.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$169.43 B 11,464.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ$2.94 B 100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ$1.48 B 1.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.13 B 455.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$19.78 B 1,250.37%๐Ÿ‡บ๐Ÿ‡ธ USA